CEN/TC 206
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 80820 | LVS EN ISO 10993-5:2009/A11:2025 | Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity | Standarts spēkā |
| 77939 | LVS EN ISO 10993-4:2017/A1:2025 | Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood - Amendment 1 (ISO 10993-4:2017/Amd 1:2025, Corrected version 2025-04) | Standarts spēkā |
| 65727 | EN ISO 10993-4:2017 | Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood (ISO 10993-4:2017) | Standarts spēkā |
| 75596 | EN ISO 10993-1:2025 | Biological evaluation of medical devices - Part 1: Requirements and general principles for the evaluation of biological safety within a risk management process (ISO 10993-1:2025) | Standarts spēkā |
| 68925 | EN ISO 10993-23:2021 | Biological evaluation of medical devices - Part 23: Tests for irritation (ISO/DIS 10993-23:2019) | Standarts spēkā |
| 69998 | EN ISO 10993-2:2022 | Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO/DIS 10993-2:2020) | Standarts spēkā |
| 64034 | EN ISO 10993-7:2008/A1:2022 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals - Amendment 1 (ISO 10993-7/DAM 1:2018) | Standarts spēkā |
| 60722 | EN ISO 10993-9:2021 | Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products (ISO/DIS 10993-9:2018) | Standarts spēkā |
| 60133 | EN ISO 10993-11:2018 | Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO/DIS 10993-11:2015) | Standarts spēkā |
| 27051 | LVS EN ISO 10993-13:2010 | Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:2010) | Standarts spēkā |
Displaying 181-190 of 194 results.